Search results
Showing 271 to 285 of 303 results for breast cancer
Veliparib in combination for treating BRCA-positive, HER2-negative breast advanced cancer [ID1404]
Discontinued [GID-TA10327]
Pembrolizumab for previously treated metastatic triple negative breast cancer [ID1246]
Discontinued [GID-TA10295]
Awaiting development [GID-TA11403] Expected publication date: TBC
All NICE products on breast cancer. Includes any guidance, advice and quality standards.
Awaiting development [GID-TA11165] Expected publication date: TBC
In development [GID-TA11402] Expected publication date: TBC
In development [GID-TA11400] Expected publication date: TBC
Awaiting development [GID-TA11273] Expected publication date: TBC
Awaiting development [GID-TA11342] Expected publication date: TBC
Capivasertib with paclitaxel for untreated metastatic triple-negative breast cancer [ID6383]
Awaiting development [GID-TA11411] Expected publication date: TBC
In development [GID-NG10415] Expected publication date: TBC